These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7756795)
21. Respiratory support in preterm infants at birth. ; Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228 [TBL] [Abstract][Full Text] [Related]
22. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates. Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203 [TBL] [Abstract][Full Text] [Related]
23. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao. Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907 [TBL] [Abstract][Full Text] [Related]
24. Immunologic consequences of exogenous surfactant administration. Merritt TA; Strayer DS; Hallman M; Spragg RD; Wozniak P Semin Perinatol; 1988 Jul; 12(3):221-30. PubMed ID: 3041605 [TBL] [Abstract][Full Text] [Related]
25. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period? Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246 [TBL] [Abstract][Full Text] [Related]
26. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470 [TBL] [Abstract][Full Text] [Related]
27. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial. Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567 [TBL] [Abstract][Full Text] [Related]
28. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514 [TBL] [Abstract][Full Text] [Related]
29. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis. Rigo V; Lefebvre C; Broux I Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511 [TBL] [Abstract][Full Text] [Related]
30. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [TBL] [Abstract][Full Text] [Related]
31. [Pulmonary surfactant and the immune system]. Griese M Monatsschr Kinderheilkd; 1992 Jan; 140(1):57-61. PubMed ID: 1565109 [TBL] [Abstract][Full Text] [Related]
32. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group. McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517 [TBL] [Abstract][Full Text] [Related]
33. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group. Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894 [TBL] [Abstract][Full Text] [Related]
34. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358 [TBL] [Abstract][Full Text] [Related]
35. Lymphocyte subpopulations in bronchopulmonary dysplasia. Ballabh P; Simm M; Kumari J; Krauss AN; Jain A; Auld PA; Cunningham-Rundles S Am J Perinatol; 2003 Nov; 20(8):465-75. PubMed ID: 14703595 [TBL] [Abstract][Full Text] [Related]
36. Surfactant proteins A and D in pulmonary diseases of preterm infants. Bersani I; Speer CP; Kunzmann S Expert Rev Anti Infect Ther; 2012 May; 10(5):573-84. PubMed ID: 22702321 [TBL] [Abstract][Full Text] [Related]
37. Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Vaucher YE; Merritt TA; Hallman M; Jarvenpaa AL; Telsey AM; Jones BL Am J Dis Child; 1988 Sep; 142(9):927-30. PubMed ID: 2458035 [TBL] [Abstract][Full Text] [Related]
38. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937 [TBL] [Abstract][Full Text] [Related]
39. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. Tapia JL; Ramírez R; Cifuentes J; Fabres J; Hübner ME; Bancalari A; Mercado ME; Standen J; Escobar M J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999 [TBL] [Abstract][Full Text] [Related]
40. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]